Return to Top

Release: April 2025
Introduction
The April release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Clinical Guideline Summaries includes 3 new entries on contraceptive use, inclusive language, and clinical deterioration.
• Core Measures contains 3 new measures on excessive radiation and hospital harm.
• Nearly 300 Drugs were updated and 4 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to almost 800 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 118 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 57 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 44 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 64 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 65 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 31 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 268 Drug monographs were updated in this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings, and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 4 Drug monographs were added this quarter:
• deuruxolitinib: Treats severe alopecia areata.
• palopegteriparatide: Used for hypoparathyroidism.
• vorasidenib: Treats grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation after surgery, including biopsy, subtotal resection, or gross resection.
• xanomeline–trospium chloride: Administered for schizophrenia.
• Renamed: None.
• Removed: 5 Drug monographs were removed this quarter due to discontinuation or low usage:
• amifostine
• benzyl alcohol
• bezlotoxumab
• conivaptan hydrochloride
• copanlisib dihydrochloride.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 118 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 2 Adult Care Plans were renamed this quarter:
• Uterine leiomyomas (fibroids) [formerly, Uterine leiomyomas]
• Tendinitis and bursitis [formerly, Tendonitis and bursitis].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 57 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 44 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 22 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching Challenges

• Updated: 9 Teaching Challenges entries were reviewed for clinical accuracy and updated as needed.
• Renamed: 2 Teaching Challenges entries were renamed this quarter:
• Overcoming language barriers [formerly, Dealing with language barriers]
• Tips for teaching the patient with cognitive impairment [formerly, Tips for teaching the cognitively impaired patient].
• Renamed: None.
• Removed: None.

Teaching Concepts

• Updated: 21 Teaching Concepts entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

National Patient Safety Goals

• Updated: 13 National Patient Safety Goals entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 1 Cultural Perspectives entry was reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: 76 Core Measure entries were reviewed for clinical accuracy and updated as needed.
• New: 3 Core Measures entries were added this quarter:
• (IP-ExRad) Excessive radiation dose or inadequate image quality for diagnostic computed tomography in adults (inpatient)
• (HH-PI) Hospital harm—Pressure injury
• (HH-AKI) Hospital harm—Acute kidney injury.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 12 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 3 Clinical Guideline Summaries were added this quarter:
• Clinical deterioration: Recognizing and responding to clinical deterioration outside the ICU (2023)
• Contraceptive use: US practice recommendations (2024)
• Inclusive language: Inclusive language and environment to welcome LGBTQIA+ patients (2024).
• Renamed: 12 Clinical Guideline Summaries were renamed this quarter:
• Critical illness-related corticosteroid insufficiency: Guidelines for the use of corticosteroids in sepsis, ARDS, and CAP (2024) [formerly, Critical illness-related corticosteroid insufficiency: SCCM/ESICM guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (2017)]
• Lyme disease: IDSA, AAN, and ACR clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease (2023) [formerly, Lyme disease: IDSA, AAN, and ACR clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease (2020)]
• Multiple sclerosis: AAN evidence-based guideline on the assessment and management of psychiatric conditions in individuals with MS (2022) [formerly, Multiple Sclerosis: AAN evidence-based guideline on the assessment and management of psychiatric conditions in individuals with MS, a report (2019)]
• Multiple sclerosis: AAN practice guideline on disease-modifying therapies for adults with multiple sclerosis (2021) [formerly, Multiple sclerosis: AAN practice guideline on disease-modifying therapies for adults with multiple sclerosis (2018)]
• Multiple sclerosis: AAN summary of the evidence-based guideline on complementary and alternative medicine in multiple sclerosis (2023) [formerly, Multiple Sclerosis: AAN summary of the evidence-based guideline on complementary and alternative medicine in multiple sclerosis (2020)]
• Postural tachycardia syndrome: Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope (2020) [formerly, Postural tachycardia syndrome: Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope (2015)]
• Pulmonary fibrosis: Clinical practice guideline on the diagnosis and treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (2022) [formerly, Pulmonary fibrosis: ATS/ERS/JRS/ALAT clinical practice guideline on the treatment of idiopathic pulmonary fibrosis (2015)]
• Seizure: AAN/CNS practice parameter on the treatment of the child with a first unprovoked seizure (2024) [formerly, Seizure: AAN/CNS practice parameter on the treatment of the child with a first unprovoked seizure (2021)]
• Seizure: AAN/CNS/AES practice parameter on evaluating a first nonfebrile seizure in children (2023) [formerly, Seizure: AAN/CNS/AES practice parameter on evaluating a first nonfebrile seizure in children (2020)]
• Suicide: VA/DoD clinical practice guideline for the assessment and management of patients at risk for suicide (2024) [formerly, Suicide: VA/DoD clinical practice guideline for the assessment and management of patients at risk for suicide (2019)]
• Surgical site infection: SHEA/IDSA practice recommendation strategies to prevent surgical site infections in acute hospitals (2022) [formerly, Surgical site infection: SHEA/IDSA practice recommendation strategies to prevent surgical site infections in acute hospitals (2014)]
• Transgender health: Health care for transgender and gender diverse individuals (2024) [formerly, Transgender health: Health care for transgender and gender diverse individuals (2021)].
• Removed: 2 outdated Clinical Guideline Summaries were removed this quarter:
• Pulmonary Fibrosis: ATS/ERS/JRS/ALAT Guideline on the diagnosis of idiopathic pulmonary fibrosis (2018)
• Sarcoidosis: Diagnosis and management of sarcoidosis (2016).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 25 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 17 Teaching about Diagnostic Tests entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Teaching about Diagnostic Tests entry was renamed this quarter:
• Prolactin level [formerly, Prolactin level test].
• Removed: None.

Teaching about Treatments

• Updated: 27 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Adapted: 28 Adult Diseases and Conditions were reviewed for clinical accuracy, updated as needed, and localised for Australia and New Zealand.
• Updated: 55 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: January 2025
Introduction
The January release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Nearly 200 Drugs were updated and 7 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to nearly 1,200 additional entries in various other categories.
• And, finally, the Health Library offers 1 updated edition, please see below for details.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 130 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 131 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 49 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 60 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 60 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Treatment was renamed this quarter:
• Noninvasive positive-pressure ventilation [formerly, Noninvasive positive-pressure ventilation airway pressure].
• Removed: None.

Treatments (Pediatric)

• Updated: 36 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Treatment was renamed this quarter:
• Noninvasive positive-pressure ventilation, pediatric [formerly, Noninvasive positive-pressure ventilation airway pressure, pediatric].
• Removed: None.

Drugs

• Updated: 197 Drug monographs were updated in this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings, and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 7 Drug monographs were added this quarter:
• aprocitentan: Treats HTN in combination with other antihypertensive drugs in patients who aren't adequately controlled on other agents.
• ceftobiprole medocaril: Used for Staphylococcus aureus bloodstream infections; acute bacterial skin and skin structure infections (ABSSSI) caused by strains of S. aureus, Streptococcus pyogenes, and Klebsiella pneumoniae; and community-acquired bacterial pneumonia (CABP) caused by strains of S. aureus, Streptococcus pneumoniae (methicillin-susceptible isolates), Haemophilus influenzae, H. parainfluenzae, Escherichia coli, and K. pneumonia e.
• givinostat: Treats Duchenne muscular dystrophy (DMD).
• imetelstat: Used for low- to intermediate-risk myelodysplastic syndromes in patients with transfusion-dependent anemia who require 4 or more RBC units over 8 weeks and haven't responded to, have lost response to, or are ineligible for erythropoiesis-stimulating agents.
• resmetirom: Indicated for patients with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (stages F2 to F3) in conjunction with diet and exercise.
• sofpironium: Treats primary axillary hyperhidrosis.
• vadadustat: Used for anemia caused by CKD in patients who have required dialysis for at least 3 months.
• Renamed: None.
• Removed: 22 Drug monographs were removed this quarter due to discontinuation or low usage:
• aliskiren hemifumarate–hydroCHLOROthiazide
• amLODIPine besylate–telmisartan
• cefotaxime sodium
• quinupristin–dalfopristin
• sapropterin dihydrochloride
• saquinavir mesylate
• sebelipase alfa
• siltuximab
• sonidegib phosphate
• tafenoquine succinate
• tagraxofusp-erzs
• taliglucerase alfa
• tavaborole
• tecovirimat
• tisagenlecleucel
• trabectedin
• tucatinib
• uridine triacetate
• velaglucerase alfa
• vemurafenib
• zanubrutinib
• ziv-aflibercept.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 130 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 131 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 48 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Education

• Updated: 27 Clinical Education entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Management

• Updated: 27 Nursing Management entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 12 Cultural Perspectives were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 56 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 17 Teaching about Diagnostic Tests entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 32 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

HEALTH LIBRARY

• Lippincott Visual Nursing: A Guide to Clinical Diseases, Skills, and Treatments, 4e, by Debra P. Kantor, PhD, RN, CNE.

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Adapted: 25 Adult Diseases and Conditions were reviewed for clinical accuracy, updated as needed, and localised for Australia and New Zealand.
• Updated: 55 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 2 Adult Diseases and Conditions entries were renamed this quarter:
• Peripheral artery disease, ANZ [formerly, Arterial occlusive disease, ANZ]
• Mpox (monkeypox), ANZ [formerly, Monkeypox (mpox), ANZ].
• Removed: 4 redundant Adult Diseases and Conditions were removed this quarter:
• Cyclothymic disorder, ANZ
• Failure to thrive, ANZ
• Histrionic personality disorder, ANZ
• Hoarding disorder, ANZ.

Return to Top

Release: October 2024
Introduction
The October release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Clinical Guideline Summaries includes a new summary of clinical guidelines on suicide.
• More than 105 Drugs were updated and 2 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to nearly 900 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 140 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 63 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 46 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 62 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 63 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 44 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 105 Drug monographs were updated in this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings, and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 2 Drug monographs were added this quarter:
• cefepime–enmetazobactam: Treats complicated UTI, including pyelonephritis, caused by Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, or Enterobacter cloacae.
• iloprost (IV): Used to reduce the risk of digit amputation from severe frostbite.
• Renamed: None.
• Removed: 15 Drug monographs were removed this quarter due to discontinuation or low usage:
• lindane
• lorlatinib
• luliconazole
• lumasiran
• lusutrombopag
• mechlorethamine hydrochloride
• migalastat hydrochloride
• mogamulizumab-kpkc
• moxetumomab pasudotox-tdfk
• obiltoxaximab
• patisiran
• pexidartinib hydrochloride
• prabotulinumtoxinA-xvfs
• pralsetinib
• prasterone.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 140 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 63 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 46 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Sentinel Events

• Updated: 23 Sentinel Events were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Indicators

• Updated: 28 Quality Indicators were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Improvement Strategies

• Updated: 28 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 10 Cultural Perspectives were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 4 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 1 Clinical Guideline Summary was added this quarter:
• Suicide: Suicide and suicide risk in adolescents (2024)
• Renamed: 4 Clinical Guideline Summaries were renamed this quarter:
• Alcohol-associated liver disease: ACG clinical guideline for alcohol-associated liver disease (2024) [formerly, Alcoholic liver disease: ACG clinical guideline for alcoholic liver disease (2018)]
• Atrial fibrillation: ACC/AHA/ACCP/HRS focused update guideline for the management of patients with atrial fibrillation (2023) [formerly, Atrial fibrillation: AHA/ACC/HRS focused update guideline for the management of patients with atrial fibrillation (2019)]
• Osteoarthritis: AAOS clinical practice guideline on the management of osteoarthritis of the hip (2023) [formerly, Osteoarthritis: AAOS clinical practice guideline on the management of osteoarthritis of the hip (2017)]
• Medication safety: ISMP targeted medication safety best practices for hospitals (2024) [formerly, Medication safety: ISMP targeted medication safety best practices for hospitals (2022)]
• Removed: 4 outdated Clinical Guideline Summaries were removed this quarter:
• Soft tissue sarcoma: NCCN clinical practice guidelines for soft tissue sarcoma (2020)
• Testicular Cancer: NCCN guidelines for testicular cancer (2020)
• Uterine Neoplasms: NCCN clinical practice guideline for uterine neoplasms (2020)
• Vulvar Cancer: NCCN clinical practice guideline for vulvar cancer (squamous cell carcinoma) (2021)

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 49 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 11 Teaching about Diagnostic Tests entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 34 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Adapted: 25 Adult Diseases and Conditions were reviewed for clinical accuracy, updated as needed, and localised for Australia and New Zealand.
• Updated: 25 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed. 1 monograph was included, with an off-cycle correction.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: July 2024
Introduction
The July release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Clinical Guideline Summaries includes 3 new summaries of clinical guidelines covering management of the first and second stages of labor, premenstrual disorders, and glycemic control for critically ill children and adults.
• More than 115 Drugs were updated and 4 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to nearly 975 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 118 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Disease was renamed this quarter:
• Compartment syndrome (extremity) [formerly, Compartment syndrome].
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 60 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Long-Term Care Disease was renamed this quarter:
• Kidney stones, long-term care [formerly, Renal calculi, long-term care].
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 50 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 62 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 62 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 36 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: More than 115 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 4 Drug monographs were added this quarter:
• berdazimer (Zelsuvmi): An antiviral used to treat molluscum contagiosum.
• capivasertib (Truqap): Used in combination with fulvestrant to treat hormone receptor–positive, HER2-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN alterations following progression or recurrence after 12 months of adjuvant therapy.
• fruquintinib (Fruzaqla): Administered for metastatic colorectal cancer in those previously treated with combination chemotherapy, antivascular endothelial growth factor (VEGF) therapy, and (if warranted) antiepidermal growth factor receptor (EGFR) therapy.
• nirogacestat (Ogsiveo): Treats progressing desmoid tumors.
• Renamed: None.
• Removed: 15 Drug monographs were removed this quarter due to discontinuation or low usage:
• deoxycholic acid
• efinaconazole
• elapegademase-lvlr
• eliglustat tartrate
• elosulfase alfa
• enasidenib
• entrectinib
• fostamatinib disodium hexahydrate
• givosiran
• hydroxyprogesterone caproate
• icatibant acetate
• idelalisib
• inotersen
• inotuzumab ozogamicin
• irinotecan hydrochloride liposome

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 118 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Care Plan was renamed this quarter:
• Compartment syndrome (extremity) [formerly, Compartment syndrome].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 60 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Long-Term Care Plan was renamed this quarter:
• Kidney stones, long-term care [formerly, Renal calculi, long-term care].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 50 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 24 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Hospital-acquired Conditions

• Updated: 14 Hospital-acquired Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Indicators

• Updated: 33 Quality Indicators were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Quality Indicator was renamed this quarter:
• Postoperative hemorrhage or hematoma rate [formerly, Perioperative hemorrhage or hematoma rate].
• Removed: None.

Quality Improvement Strategies

• Updated: 33 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Quality Improvement Strategy was renamed this quarter:
• Postoperative hemorrhage or hematoma rate [formerly, Perioperative hemorrhage or hematoma rate].
• Removed: None.

Clinical Guideline Summaries

• Updated: 2 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 3 Clinical Guideline Summaries were added this quarter:
• Labor management: First and second stage labor management (2024)
• Premenstrual disorders: Management of premenstrual disorders (2023)
• Glycemic control: Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults (2024)
• Renamed: 2 Clinical Guideline Summaries were renamed this quarter:
• Diabetes mellitus: ADA standards of medical care in diabetes (2024) [formerly, Diabetes mellitus: ADA standards of medical care in diabetes (2022)]
• Headache: VA/DoD clinical practice guideline for the management of headache (2023) [formerly, Headache: VA/DoD clinical practice guideline for the primary care management of headache (2020)]
• Removed: 5 outdated Clinical Guideline Summaries were removed this quarter:
• Pheochromocytoma: Endocrine Society clinical practice guideline on pheochromocytoma and paraganglioma (2014)
• Prostate cancer: NCCN guidelines on prostate cancer (2020)
• Rectal cancer: NCCN clinical practice guidelines for rectal cancer (2020)
• Small bowel adenocarcinoma: NCCN clinical practice guidelines for small bowel adenocarcinoma (2021)
• Small cell lung cancer: NCCN guidelines for small cell lung cancer (2021).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 52 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Teaching about Diseases entry was renamed this quarter:
• Compartment syndrome (extremity) [formerly, Compartment syndrome].
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 32 Teaching about Diagnostic Tests entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 2 Teaching about Diagnostic Test entries were renamed this quarter:
• Echocardiography [formerly, Echocardiogram].
• Erythrocyte sedimentation rate test [formerly, Erythrocyte sedimentation rate].
• Removed: None.

Teaching about Treatments

• Updated: 39 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Adapted: 25 Adult Diseases and Conditions were reviewed for clinical accuracy, updated as needed, and localised for Australia and New Zealand.
• Updated: 30 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: April 2024
Introduction
The April release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Core Measures features 2 new entries on screening for social drivers of health.
• Clinical Guideline Summaries offers 4 new summaries of clinical guidelines covering bipolar disorder, chest pain, inpatient fall prevention, and testicular cancer.
• Over 850 Drugs were updated and 8 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to more than 1,000 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 119 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Disease was renamed this quarter:
• Kidney stones [formerly, Renal calculi].
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 62 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 44 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 63 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Diagnostic Test was renamed this quarter:
• Clostridioides toxin assay [formerly, Clostridium toxin assay].
• Removed: None.

Treatments (Adult)

• Updated: 65 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 31 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: More than 850 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 8 Drug monographs were added this quarter:
• avacincaptad pegol (Izervay): Treats geographic atrophy secondary to age-related macular degeneration (AMD).
• etrasimod (Velsipity): For moderate to severe active ulcerative colitis.
• gepirone (Exxua): Administered for major depressive disorder.
• momelotinib (Ojjaara): Treats intermediate or high-risk myelofibrosis in patients with anemia.
• motixafortide (Aphexda): Used in combination with filgrastim to mobilize hematopoietic stem cells to peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.
• palovarotene (Sohonos): Used for reduction in volume of new heterotopic ossification in patients with fibrodysplasia ossificans progressiva.
• vamorolone (Agamree): Treats Duchenne muscular dystrophy (DMD).
• zilucoplan (Zilbrysq): For generalized myasthenia gravis in patients who are anti-acetylcholine receptor antibody-positive.
• Renamed: None.
• Removed: 20 Drug monographs were removed this quarter due to discontinuation or low usage:
• afamelanotide
• afatinib dimaleate
• aflibercept
• alglucosidase alfa
• amifampridine
• amikacin liposome inhalation suspension
• artemether–lumefantrine
• asfotase alfa
• bepotastine besilate
• bexarotene
• bosutinib
• bremelanotide
• brigatinib
• burosumab-twza
• canakinumab
• carglumic acid
• cenegermin-bkbj
• cerliponase alfa
• crizotinib
• dacomitinib.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 119 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Care Plan was renamed this quarter:
• Kidney stones [formerly, Renal calculi].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 62 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 44 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 22 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

National Patient Safety Goals

• Updated: 13 National Patient Safety Goals were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: 74 Core Measures were reviewed for clinical accuracy and updated as needed.
• New: 2 Core Measures were added this quarter:
• (SDOH-1) Screening for social drivers of health
• (SDOH-2) Screen positive rate for social drivers of health.
• Removed: None.

Clinical Guideline Summaries

• Updated: 6 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 4 Clinical Guideline Summaries were added this quarter:
• Bipolar disorder: VA/DoD clinical practice guideline for the management of bipolar disorder (2023)
• Chest pain: Evaluation and diagnosis (2021)
• Fall prevention: Best practices for developing an inpatient program to prevent older adult falls after discharge (2021)
• Testicular cancer: Diagnosis and treatment of early-stage testicular cancer (2023)
• Renamed: 6 Clinical Guideline Summaries were renamed this quarter:
• Beers Criteria®: American Geriatrics Society updated AGS Beers Criteria® for potentially inappropriate medication use in older adults (2023) [formerly, Beers Criteria: American Geriatrics Society AGS Beers Criteria for potentially inappropriate medication use in older adults (2019)]
• Benign prostatic hyperplasia: AUA guideline for the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (2023) [formerly, Benign prostatic hyperplasia: AUA guideline for the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (2021)]
• CAUTI: Strategies to prevent catheter-associated urinary tract infections in acute hospitals (2022) [formerly, CAUTI: Strategies to prevent catheter-associated urinary tract infections in acute hospitals (2014)]
• Pregnancy: VA/DoD clinical practice guideline for the management of pregnancy (2023) [formerly, Pregnancy: VA/DoD clinical practice guideline for the management of pregnancy (2018)].
• Osteoporosis: ACR guideline for the prevention and treatment of glucocorticoid-induced osteoporosis (2022) [formerly, Osteoporosis: ACR guideline for the prevention and treatment of glucocorticoid-induced osteoporosis (2017)]
• Posttraumatic stress disorder: VA/DoD guideline for the management of posttraumatic stress disorder and acute stress disorder (2023) [formerly, Posttraumatic stress disorder: VA/DoD guideline for the management of posttraumatic stress disorder and acute stress disorder (2017)].
• Removed: 5 outdated Clinical Guideline Summaries were removed this quarter:
• Multiple myeloma: NCCN guidelines on multiple myeloma (2020)
• Neuroendocrine and adrenal tumors: NCCN clinical practice guidelines in oncology: Neuroendocrine and adrenal tumors (2021)
• Non-small cell lung cancer: NCCN guidelines on non-small cell lung cancer (2020)
• Ovarian cancer: NCCN guidelines on ovarian cancer including fallopian tube cancer and primary peritoneal cancer (2020)
• Pancreatic adenocarcinoma: NCCN guidelines for pancreatic adenocarcinoma (2020).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 54 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Care Plan was renamed this quarter:
• Kidney stones [formerly, Renal calculi].
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 27 Teaching about Diagnostic Tests entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 27 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Teaching about Treatments entry was renamed this quarter:
• Transcatheter aortic valve replacement (TAVR), percutaneous [formerly, Transcatheter aortic valve replacement].
• Removed: None.

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Adapted: 25 Adult Diseases and Conditions were reviewed for clinical accuracy, updated as needed, and localised for Australia and New Zealand.
• Updated: 30 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Diseases and Conditions entry was renamed this quarter:
• Amniotic fluid embolism, ANZ [formerly, Anaphylactoid syndrome of pregnancy, ANZ].
• Removed: 4 redundant Adult Diseases and Conditions were removed this quarter:
• Cyclothymic disorder, ANZ
• Failure to thrive, ANZ
• Histrionic personality disorder, ANZ
• Hoarding disorder, ANZ.

Return to Top

Release: January 2024
Introduction
The January release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Adult Care Plans features 2 new psychiatric conditions on Delirium and Gender dysphoria.
• Clinical Guideline Summaries offers 5 new summeries of clinical guidelines covering the diagnosis and management of celiac disease; evaluation and treatment of children and adolescents with obesity; management of first episode psychosis and schizophrenia; strategies to reduce racial and ethnic inequities in stroke preparedness, care, recovery, and risk factor control; and treatment of hypercalcemia of malignancy in adults.
• 206 Drugs were updated and 7 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to more than 1,000 additional entries in various other categories.
• And don't forget to check out the Health Library's new look!

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 129 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 66 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 48 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 63 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 60 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 36 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 206 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 7 Drug monographs were added this quarter:
• fezolinetant (Veozah): Treats moderate to severe vasomotor symptoms due to menopause.
• lotilaner (Xdemvy): Ophthalmic solution for treatment of Demodex blepharitis.
• nirmatrelvir-ritonavir (Paxlovid): Administered for moderate COVID-19 in patients at high risk for progression to severe COVID-19, including hospitalization or death.
• perfluorohexyloctane (Miebo): Ophthalmic solution for dry eye disease.
• ritlecitinib (Litfulo): Perscribed for those with severe alopecia areata.
• sotagliflozin (Inpefa): Used to reduce risk of CV death, hospitalization for HF, and urgent visits in patients with HF or type 2 diabetes, CKD, and other CV risk factors.
• sulbactam-durlobactam (Xacduro): Treats hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.
• Renamed: None.
• Removed: 2 Drug monographs were discontinued and removed this quarter:
• brodalumab
• oxycodone hydrochloride-aspirin.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 129 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 2 new Adult Care Plans were added this quarter:
• Delirium
• Gender dysphoria.
• Renamed: 1 Adult Care Plan was renamed this quarter:
• Mpox [formerly, Monkeypox].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 66 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 48 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 15 Cultural Perspectives were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Communication

• Updated: 25 Communication entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: None.
• New: 2 Core Measures were added this quarter:
• (GMCS) Global malnutrition composite score
• (HH-ORAE) Hospital Harm - Opioid-related adverse events.
• Removed: None.

Clinical Guideline Summaries

• Updated: 5 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 5 Clinical Guideline Summaries were added this quarter:
• Celiac disease: ACG guidelines on the diagnosis and management of celiac disease (2023)
• Obesity: Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity (2023)
• Schizophrenia: Management of first episode psychosis and schizophrenia (2023)
• Stroke: Strategies to reduce racial and ethnic inequities in stroke preparedness, care, recovery and risk factor control (2023)
• Hypercalcemia of malignancy: Treatment of hypercalcemia of malignancy in adults (2023).
• Renamed: 4 Clinical Guideline Summaries were renamed this quarter:
• Diabetes mellitus type 2: VA/DoD clinical practice guideline for the management of type 2 diabetes mellitus (2023) [formerly, Diabetes mellitus type 2: VA/DoD clinical practice guideline for the management of type 2 diabetes mellitus in primary care (2017)]
• Hepatitis C: AASLD-IDSA updated guideline recommendations for testing, managing, and treating hepatitis C virus infection (2023) [formerly, Hepatitis C: AASLD-IDSA updated guideline recommendations for testing, managing, and treating hepatitis C virus infection (2019)]
• Major depressive disorder: Treatment of adults in the acute phase of major depressive disorder (2023) [formerly, Major depressive disorder: ACP clinical practice guideline on the nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder (2016)]
• Obstructive sleep apnea: Referral of adults with obstructive sleep apnea for surgical consultation (2021) [formerly, Obstructive sleep apnea: Practice parameters for the surgical modifications of the upper airway for obstructive sleep apnea in adults (2010)].
• Removed: 5 outdated Clinical Guideline Summaries were removed this quarter:
• Esophageal cancer: NCCN clinical practice guidelines for esophageal and esophagogastric junction cancers (2020)
• Head and neck cancers: NCCN clinical practice guideline for head and neck cancers (2021)
• Hodgkin lymphoma: NCCN clinical practice guideline for Hodgkin lymphoma (2020)
• Cutaneous melanoma: NCCN clinical practice guidelines on cutaneous melanoma (2019)
• Malignant pleural mesothelioma: NCCN clinical practice guideline for malignant mesothelioma (2020).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 54 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 11 Teaching about Diagnostic Tests entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 32 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 30 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 25 new Adult Diseases and Conditions adaptations were added this quarter:
• Acquired immune deficiency syndrome (AIDS) and human immunodeficiency virus (HIV), ANZ (adapted)
• Anaemia (iron deficiency), ANZ (adapted)
• Blood transfusion reaction, ANZ (adapted)
• Disseminated intravascular coagulation, ANZ (adapted)
• Hearing loss, ANZ (adapted)
• Intellectual disability, ANZ (adapted)
• Labyrinthitis, ANZ (adapted)
• Laryngitis, ANZ (adapted)
• Latex allergy, ANZ (adapted)
• Major depressive disorder, ANZ (adapted)
• Ménière disease, ANZ (adapted)
• Narcissistic personality disorder, ANZ (adapted)
• Obsessive-compulsive disorder, ANZ (adapted)
• Otitis externa, ANZ (adapted)
• Otitis media, ANZ (adapted)
• Otosclerosis, ANZ (adapted)
• Pharyngitis, ANZ (adapted)
• Reactive arthritis, ANZ (adapted)
• Rheumatoid arthritis, ANZ (adapted)
• Rhinosinusitis, ANZ (adapted)
• Scleroderma, ANZ (adapted)
• Serum sickness, ANZ (adapted)
• Sjögren disease, ANZ (adapted)
• Thrombocytopenia, ANZ (adapted)
• Tonsillitis, ANZ (adapted)
• Renamed: None.
• Removed: None.

Return to Top

Release: October 2023
Introduction
The October release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Adult Diseases and Conditions features 2 new psychiatric conditions on Delirium and Gender dysphoria.
• Clinical Guideline Summaries offers 5 new entries covering various health topics, including Early mobilization and rehabilitation of critically burned patients; KDIGO clinical practice guideline on diabetes and chronic kidney disease; APA guideline for the treatment of patients with eating disorders; Strategies to prevent health care-associated infections through hand hygiene; and Diagnosis and management of pediatric patients with acute respiratory distress syndrome.
• Cultural Perspectives offers insightful guidance for nurses and other clinicians as they encounter patients and families from various diverse backgrounds, ensuring the delivery of equitable, culturally competent care across the health care continuum. In this release, you'll find helpful advice that focuses on dealing with the unique perspectives of two additional patient populations: Nepalis and Ukrainians.
• 120 Drugs were updated and 5 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to more than 1,100 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 139 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 2 Adult Diseases and Conditions were added this quarter:
• Delirium
• Gender dysphoria.
• Renamed: 2 Adult Diseases and Conditions were renamed this quarter:
• Alcohol use disorder [formerly, Alcoholism]
• Mpox [formerly, Monkeypox].
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 63 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Long-Term Care Disease was renamed this quarter:
• Alcohol use disorder, long-term care [formerly, Alcoholism, long-term care].
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 46 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 63 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 2 Adult Treatments were renamed this quarter:
• Fecal microbiota transplantation [formerly, Fecal bacteriotherapy]
• Hyperbaric oxygen therapy [formerly, Hyperbaric oxygenation].
• Removed: None.

Treatments (Pediatric)

• Updated: 44 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Pediatric Treatment was renamed this quarter:
• Hyperbaric oxygen therapy, pediatric [formerly, Hyperbaric oxygenation, pediatric].
• Removed: None.

Signs and Symptoms

• Updated: 81 Signs and Symptoms were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 120 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 5 Drug monographs were added this quarter:
• leniolisib (Joenja): Immunomodulator that treats a rare genetic condition, activated phosphoinositide 3-kinase delta syndrome (APDS), which affects the immune system.
• omaveloxolone (Skyclarys): Indicated for the treatment of Friedreich ataxia, a rare, inherited, degenerative disease that damages the nervous system.
• sparsentan (Filspari): Reduces proteinuria in patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease progression.
• trofinetide (Daybue): Used to treat Rett syndrome, a rare, genetic neurological and developmental disorder that affects the way the brain develops.
• zavegepant (Zavzpret): Nasal spray used for the acute treatment of migraine with or without aura in adults.
• Renamed: None.
• Removed: 1 Drug monograph was discontinued and removed this quarter:
• nelfinavir mesylate.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 139 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Care Plan was renamed this quarter:
• Alcohol use disorder [formerly, Alcoholism].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 63 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Long-Term Care Plan was renamed this quarter:
• Alcohol use disorder, long-term care [formerly, Alcoholism, long-term care].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 46 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 15 Cultural Perspectives were reviewed for clinical accuracy and updated as needed.
• New: 2 Cultural Perspectives were added this quarter:
• Nepalis
• Ukrainians.
• Renamed: None.
• Removed: None.

Sentinel Events

• Updated: 23 Sentinel Events were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: 72 Core Measures were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 2 Core Measures were renamed this quarter:
• (HH-Hyper) Hospital Harm - Severe hyperglycemia [formerly, (HH-02) Hospital Harm - Severe hyperglycemia]
• (HH-Hypo) Hospital Harm - Severe hypoglycemia [formerly, (HH-01) Hospital Harm - Severe hypoglycemia]
• Removed: None.

Clinical Guideline Summaries

• Updated: 4 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 5 Clinical Guideline Summaries were added this quarter:
• Burns: Early mobilization and rehabilitation of critically ill burn patients (2022)
• Diabetes and chronic kidney disease: KDIGO 2022 clinical practice guideline (2022)
• Eating disorders: APA guideline for the treatment of patients with eating disorders (2023)
• Hand hygiene: SHEA/IDSA/APIC strategies to prevent healthcare-associated infections through hand hygiene (2023)
• Pediatric acute respiratory distress syndrome: Second international guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (2023)
• Renamed: 4 Clinical Guideline Summaries were renamed this quarter:
• Diabetes mellitus: AACE guidelines for developing a diabetes mellitus comprehensive care plan (2022) [formerly, Diabetes mellitus type 1: AACE/ACE guidelines for developing a diabetes mellitus comprehensive care plan (2015)]
• Nonalcoholic fatty liver disease: Practice guidance from the AASLD on the diagnosis and management of nonalcoholic fatty liver disease (2023) [formerly, Nonalcoholic fatty liver disease: Practice guidance from the AASLD on the diagnosis and management of nonalcoholic fatty liver disease (2018)]
• Postpartum pain management: ACOG committee opinion on postpartum pain management (2021) [formerly, Postpartum Pain Management: ACOG Committee Opinion, Number 742, Postpartum Pain Management (2018)]
• Pulmonary hypertension: ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension (2022) [formerly, Pulmonary hypertension: 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension (2016)]
• Removed: 5 outdated Clinical Guideline Summaries were removed this quarter:
• Bladder cancer: NCCN clinical practice guideline for bladder cancer (2020)
• Bone cancer: NCCN clinical practice guideline for bone cancer (2019)
• Breast cancer: NCCN clinical practice guidelines on breast cancer (2020)
• Cervical cancer: NCCN clinical practice guidelines for cervical cancer (2020)
• Colon cancer: NCCN clinical practice guidelines for colon cancer (2020)

Quality Indicators

• Updated: 28 Quality Indicators were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Quality Indicator was renamed this quarter:
• Unplanned reoperation within the 30-day postoperative period [formerly, Unplanned return to operating room rate].
• Removed: None.

Quality Improvement Strategies

• Updated: 28 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Quality Improvement Strategy was renamed this quarter:
• Unplanned reoperation within the 30-day postoperative period [formerly, Unplanned return to operating room rate].
• Removed: None.

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 48 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: 1 Teaching about Diseases entry was added this quarter:
• Delirium
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 34 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 26 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: July 2023
Introduction
The July release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Long-Term Care Diseases and Conditions features a new entry on COVID-19: Coronavirus disease 2019 (COVID-19), long-term care.
• Likewise, Long-Term Care Plans offers a complementary entry titled Coronavirus disease 2019 (COVID-19), long-term care.
• Clinical Guideline Summaries provides 4 new guideline summaries covering alcohol withdrawal, hepatic encephalopathy, pediatric oral health, and pediatric safety.
• National Patient Safety Goals includes a new entry dealing with improving health care equity among hospitalized patients.
• Over 130 Drugs were updated and 8 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to more than 800 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 120 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 60 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 1 Long-term Care Disease was added this quarter:
• Coronavirus disease 2019 (COVID-19), long-term care.
• Renamed: 1 Long-term Care Disease was renamed this quarter:
• Tourette disorder, long-term care [formerly, Tourette syndrome, long-term care].
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 50 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 62 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Treatment was renamed this quarter:
• Continuous kidney replacement therapy [formerly, Continuous renal replacement therapy].
• Removed: None.

Treatments (Pediatric)

• Updated: 36 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 133 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 8 Drug monographs were added this quarter:
• adagrasib (Krazati): Helps patients with KRAS G12C-mutated locally advanced or metastatic NSCLC who have received at least one prior systemic therapy.
• bexagliflozin (Brenzavvy): Adjunct to diet and exercise to improve glycemic control in type 2 diabetes.
• daprodustat (Jesduvroq): Reduces anemia due to chronic kidney disease in patients who have been receiving dialysis for at least 4 months.
• elacestrant (Orserdu): Treats patients with estrogen receptor-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.
• lecanemab-irmb (Leqembi): Reduces amyloid beta plaques in those with a mild cognitive impairment or mild dementia stage of Alzheimer disease.
• lenacapavir (Sunlenca): Given in combination with other antiretrovirals in heavily treatment-experienced patients with multidrug-resistant HIV-1 infection who are failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations.
• olutasidenib (Rezlidhia): Treats relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation.
• pirtobrutinib (Jaypirca): Treats relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including Bruton tyrosine kinase (BTK) inhibitor.
• Renamed: None.
• Removed: 2 Drug monographs were discontinued and removed this quarter:
• miltefosine
• panobinostat lactate.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 118 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 60 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 1 Long-Term Care Plan was added this quarter:
• Coronavirus disease 2019 (COVID-19), long-term care.
• Renamed: 1 Long-Term Care Plan was renamed this quarter:
• Tourette disorder, long-term care [formerly, Tourette syndrome, long-term care].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 44 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Pediatric Care Plan was renamed this quarter:
• Tourette disorder, pediatric [formerly, Tourette syndrome, pediatric].
• Removed: None.

Problem-based Care Plans

• Updated: 24 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Signs and Symptoms

• Updated: 71 Signs and Symptoms were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 17 Cultural Perspectives were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Cultural Perspectives entry was renamed this quarter:
• Lesbian, gay, bisexual, transgender, queer, intersex, asexual (LGBTQIA+) community (adults) [formerly, Lesbian, gay, bisexual, transgender, queer, (LGBTQ) community (adults)].
• Removed: None.

Hospital-acquired Conditions

• Updated: 14 Hospital-acquired Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Indicators

• Updated: 33 Quality Indicators were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Improvement Strategies

• Updated: 33 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

National Patient Safety Goals

• Updated: None.
• New: 1 National Patient Safety Goal was added this quarter:
• (NPSG.16.01.01) Health care equity.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 7 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 4 Clinical Guideline Summaries were added this quarter:
• Alcohol withdrawal: The ASAM clinical practice guideline on alcohol withdrawal management (2020)
• Hepatic encephalopathy: Clinical practice guideline on the management of hepatic encephalopathy (2022)
• Pediatric oral health: Maintaining and improving the oral health of young children (2023)
• Pediatric safety: Optimizing pediatric patient safety in the emergency care setting (2022).
• Renamed: 6 Clinical Guideline Summaries were renamed this quarter:
• Chronic obstructive pulmonary disease: Global strategy for the diagnosis, management, and prevention of COPD, a report (2022) [formerly, Chronic obstructive pulmonary disease: Global strategy for the diagnosis, management, and prevention of COPD, a report (2020)]
• Osteoarthritis: Surgical management of osteoarthritis of the knee (2022) [formerly, Osteoarthritis: AAOS evidenced-based guideline on surgical management of osteoarthritis of the knee (2015)]
• Osteoporosis: Pharmacologic treatment of low bone density or osteoporosis to prevent fractures in men and women (2023) [formerly, Osteoporosis: ACP clinical practice guideline on the treatment of low bone density or osteoporosis to prevent fractures in men and women (2017)]
• Seizure: AAN/CNS/AES practice parameter on evaluating a first nonfebrile seizure in children (2020) [formerly, Seizure: AAN/CNS/AES practice parameter on evaluating a first nonfebrile seizure in children (2000)]
• Seizure: AAN/CNS practice parameter on the treatment of the child with a first unprovoked seizure (2021) [formerly, Seizure: AAN/CNS practice parameter on the treatment of the child with a first unprovoked seizure (2003)]
• Valvular heart disease: ACC/AHA guideline for the management of patients with valvular heart disease (2020) [formerly, Valvular heart disease: AHA/ACC focused update of the 2014 guideline for the management of patients with valvular heart disease (2017)].
• Removed: 5 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Hepatic encephalopathy: AASLD and EASL practice guideline on hepatic encephalopathy in chronic liver disease (2014)
• Acute myeloid leukemia: NCCN clinical practice guideline for acute myeloid leukemia (2019)
• Acute lymphoblastic leukemia: NCCN clinical practice guideline for acute lymphoblastic leukemia (2018)
• Anal carcinoma: NCCN clinical practice guidelines for anal carcinoma (2021)
• B-cell lymphomas: NCCN clinical practice guidelines in oncology: B-cell lymphomas (2020).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 52 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 39 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: June 2023
Introduction
The June release of Lippincott Advisor ANZ (Australia - New Zealand Edition) reflects the following enhancements:

LIPPINCOTT ADVISOR ANZ CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 30 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: April 2023
Introduction
The April release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Pediatric Diseases and Conditions features the new entry Multisystem inflammatory syndrome in children, pediatric.
• Likewise, Pediatric Care Plans offers a complementary entry also titled Multisystem inflammatory syndrome in children, pediatric.
• Adult Treatments features 3 new treatments on Endovascular embolization, spinal; Peritoneovenous shunt; and Sialendoscopy.
• Diagnostic Tests includes 3 new entries on Instantaneous wave-free ratio, Liver biopsy (transjugular), and Procainamide challenge.
• Clinical Guideline Summaries provides 6 new guideline summaries covering Endometriosis, Hyperglycemia, Irritable bowel syndrome with constipation, Irritable bowel syndrome with diarrhea, Surgical site infection, and Tympanostomy tubes.
• Over 850 Drugs were updated and 4 new FDA-approved drugs were added this quarter (see details below).
• You'll also find updates to more than 950 additional entries in various other categories.
• And, finally, the Health Library offers 1 new edition of a previously published text, plus 2 new titles (see below for further details).

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 120 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Disease was renamed this quarter:
• Tourette disorder [formerly, Tourette syndrome].
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 62 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 46 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 1 Pediatric Disease was added this quarter:
• Multisystem inflammatory syndrome in children, pediatric.
• Renamed: 1 Pediatric Disease was renamed this quarter:
• Tourette disorder, pediatric [formerly, Tourette syndrome, pediatric].
• Removed: None.

Treatments (Adult)

• Updated: 61 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: 3 Adult Treatments were added this quarter:
• Endovascular embolization, spinal
• Peritoneovenous shunt
• Sialendoscopy.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 31 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 1 Diagnostic Test was reviewed for clinical accuracy and updated as needed.
• New: 3 Diagnostic Tests were added this quarter:
• Instantaneous wave-free ratio
• Liver biopsy (transjugular)
• Procainamide challenge.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 855 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 4 Drug monographs were added this quarter:
• deucravacitinib (Sotyktu): Treats plaque psoriasis in patients who are candidates for systemic therapy or phototherapy.
• terlipressin (Terlivaz): Improves kidney function in patients with hepatorenal syndrome with rapid reduction in kidney function.
• omidenepag isopropyl ophthalmic solution (Omlonti): Reduction of elevated IOP in patients with open-angle glaucoma or ocular HTN.
• sodium phenylbutyrate and taurursodiol (Relyvrio): Treats ALS.
• Renamed: None.
• Removed: 5 Drug monographs were discontinued and removed this quarter:
• abciximab
• darunavir
• eprosartan mesylate
• indinavir
• tenofovir disoproxil fumarate.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 119 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Adult Care Plan was renamed this quarter:
• Tourette disorder [formerly, Tourette syndrome].
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 62 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 44 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 1 Pediatric Care Plan was added this quarter:
• Multisystem inflammatory syndrome in children, pediatric.
• Renamed: 1 Pediatric Care Plan was renamed this quarter:
• Tourette disorder, pediatric [formerly, Tourette syndrome, pediatric].
• Removed: None.

Problem-based Care Plans

• Updated: 22 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: 70 Core Measures were reviewed for clinical accuracy and updated as needed.
• New: 2 Core Measures were added this quarter:
• (HH-01) Hospital Harm - Severe hypoglycemia
• (HH-02) Hospital Harm - Severe hyperglycemia.
• Renamed: None.
• Removed: None.

Signs and Symptoms

• Updated: 76 Signs and Symptoms were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

National Patient Safety Goals

• Updated: 12 National Patient Safety Goals were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 6 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 6 Clinical Guideline Summaries were added this quarter:
• Endometriosis: Guidelines for management (2022)
• Hyperglycemia: Management of hyperglycemia in hospitalized adult patients in non-critical care settings (2022)
• Irritable bowel syndrome: AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with constipation (2022)
• Irritable bowel syndrome: AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea (2022)
• Surgical site infection: Prevention of surgical site infection after major extremity trauma (2022)
• Tympanostomy tubes: Clinical practice guideline summary (2022).
• Renamed: 6 Clinical Guideline Summaries were renamed this quarter:
• Acquired immunodeficiency syndrome: Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV (2022) [formerly, Acquired immunodeficiency syndrome: CDC/NIH/HIV Medicine Association of the IDSA guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents (2021)]
• Acquired immunodeficiency syndrome: Guidelines for the use of antiretroviral agents in adults and adolescents with HIV (2022) [formerly, Acquired immunodeficiency syndrome: DHHS guidelines for the use of antiretroviral agents in adults and adolescents with HIV (2021)]
• Benign prostatic hyperplasia: AUA guideline for the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (2021) [formerly, Benign prostatic hyperplasia: AUA guideline for the surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (2019)]
• Colon cancer: American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of colon cancer (2022) [formerly, Colon cancer: American Society of Colon and Rectal Surgeons clinical practice guidelines for the treatment of colon cancer (2017)]
• Gastroparesis: Clinical guideline on the Management of gastroparesis (2022) [formerly, BGastroparesis: Clinical guideline on the Management of gastroparesis (2013)]
• Migraine: The American Headache Society update on integrating new migraine treatments into clinical practice (2021) [formerly, Migraine: The American Headache Society position statement on integrating new migraine treatments into clinical practice (2019)].
• Removed: 6 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Colorectal surgery: ASER/POQI Joint Consensus Statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery (2018)
• Diabetes and pregnancy: An Endocrine Society Clinical Practice Guideline on diabetes and pregnancy (2013)
• Gout: ACP Clinical Practice Guideline on the management of acute and recurrent gout (2017)
• Gynecologic oncology surgery: Enhanced Recovery After Surgery Society guideline recommendations for pre- and intra-operative care in gynecologic/oncology surgery, part I (2016)
• Gynecologic oncology surgery: ERAS guidelines for pre- and intra-operative care in gynecologic/oncology surgery, part I (2016)
• Microscopic colitis: AGA guideline on the medical management of microscopic colitis (2016).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 26 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 27 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

HEALTH LIBRARY

• Updated: 1 new edition was added this quarter:
• LWW: Lippincott Nursing Procedures, 9th ed. (Replaces Lippincott Nursing Procedures, 8th ed.)
• New: 2 new titles were added this quarter:
• Carter: Lippincott Essentials for Nursing Assistants: A Humanistic Approach to Caregiving, 5th ed.
• Carter: Lippincott Acute Care Skills for Advanced Nursing Assistants: A Humanistic Approach to Caregiving, 1st ed.
• Renamed: None.
• Removed: None.

Return to Top

Release: March 2023
Introduction
The March release of Lippincott Advisor ANZ (Australia - New Zealand Edition) reflects the following enhancements:

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 30 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: January 2023
Introduction
The January release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Pediatric Diseases and Conditions features the new entry Parechovirus, pediatric.
• Likewise, Pediatric Care Plans offers a complementary entry also titled Parechovirus, pediatric.
• Long-Term Care Diseases features 3 new entries on headaches to replace the general headache entry: Headache (cluster), long-term care; Headache (migraine), long-term care; and Headache (tension), long-term care.
• In addition, Long-Term Care Plans offers 3 new complementary entries with the same titles.
• Adult Treatments includes 4 new treatments on Neurolysis and plexus infiltration, Rotational coronary atherectomy, Transcatheter atrial septal defect (ASD) repair, and Transcatheter patent foramen ovale closure.
• Diagnostic Tests features 1 new entry covering Parathyroid vein sampling.
• Clinical Guideline Summaries provides 4 new guideline summaries on Fall prevention, Newborn cardiovascular insufficiency, Opioid use and chronic pain, and Sleep-related infant deaths.
• Drugs includes 6 new FDA-approved drugs this quarter (see details below).
• You'll also find updates to more than 950 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 129 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 63 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 3 Long-Term Care Diseases were added this quarter:
• Headache (cluster), long-term care
• Headache (migraine), long-term care
• Headache (tension), long-term care.
• Renamed: None.
• Removed: 1 Long-Term Care Disease entry was removed this quarter:
• Headache, long-term care.

Diseases and Conditions (Pediatric)

• Updated: 46 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 1 Pediatric Diseases entry was added this quarter:
• Parechovirus, pediatric.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 54 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: 4 Adult Treatments were added this quarter:
• Neurolysis and plexus infiltration
• Rotational coronary atherectomy
• Transcatheter atrial septal defect (ASD) repair
• Transcatheter patent foramen ovale closure.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 36 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: None.
• New: 1 Diagnostic Test entry was added this quarter:
• Parathyroid vein sampling.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 206 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 6 Drug monographs were added this quarter:
• tapinarof (Vtama): Treats plaque psoriasis.
• tirzepatide (Mounjaro): Improves glycemic control in adults with type 2 diabetes.
• ursodiol: Assists in gallstone dissolution, helps gallstone prevention in patients undergoing rapid weight loss, and treats primary biliary cholangitis.
• vonoprazan–amoxicillin (Voquenza Dual Pak): Treats Helicobacter pylori infection.
• vonoprazan–amoxicillin–clarithromycin (Voquenza Triple Pak): Treats H. pylori infection.
• vutrisiran (Amvuttra): Treats polyneuropathy of hereditary transthyretin-mediated amyloidosis.
• Renamed: None.
• Removed: 1 Drug monograph was discontinued and removed this quarter:
• asparaginase Erwinia chrysanthemi.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 129 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 63 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 3 Long-Term Care Plans were added this quarter:
• Headache (cluster)
• Headache (migraine)
• Headache (tension).
• Renamed: None.
• Removed: 1 Long-Term Care Plan was removed this quarter:
• Headache, long-term care.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 46 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 1 Pediatric Care Plan was added this quarter:
• Parechovirus, pediatric.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 12 Cultural Perspectives were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 4 Cultural Perspectives were renamed this quarter:
• Pakistanis [formerly, Pakistani]
• Poles [formerly, Polish]
• Spaniards [formerly, Spanish]
• Turks [formerly, Turkish].
• Removed: None.

Signs and Symptoms

• Updated: 75 Signs and Symptoms were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 4 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 4 Clinical Guideline Summaries were added this quarter:
• Fall prevention: Preventing and managing falls in adults with cardiovascular disease (2022)
• Newborn cardiovascular insufficiency: Recognition and management of cardiovascular insufficiency in the very low birth weight newborn (2022)
• Opioid use and chronic pain: VA/DoD clinical practice guideline for the use of opioids in the management of chronic pain (2022)
• Sleep-related infant deaths: Recommendations for reducing infant deaths in the sleep environment (2022).
• Renamed: 4 Clinical Guideline Summaries were renamed this quarter:
• Crohn disease: Clinical practice guideline for the surgical management of Crohn disease (2020) [formerly, Crohn disease: Clinical practice guideline for the surgical management of Crohn disease (2015)]
• Medication safety: ISMP targeted medication safety best practices for hospitals (2022) [formerly, Medication safety: ISMP targeted medication safety best practices for hospitals (2020)]
• Prostate cancer: AUA/ASTRO guideline on clinically localized prostate cancer (2022) [formerly, Prostate cancer: AUA/ASTRO/SUO guideline on clinically localized prostate cancer (2017)]
• Seizure: AAN/AES evidenced-based guideline on the management of an unprovoked first seizure in adults (2021) [formerly, Seizure: AAN/AES evidenced-based guideline on the management of an unprovoked first seizure in adults (2015)].
• Removed: 6 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Acute liver failure: American Gastroenterological Association Institute guidelines for the diagnosis and management of acute liver failure (2017)
• Gastric cancer: NCCN clinical practice guideline for gastric cancer (2018)
• Hyperkalemia: NKF best practices in managing hyperkalemia in chronic kidney disease (2016)
• Irritable bowel syndrome: AGA guideline on the pharmacological management of IBS (2014)
• Kidney cancer: NCCN clinical practice guideline for kidney cancer (2020)
• Kidney injury acute: KDIGO clinical practice guideline for acute kidney injury (2012).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 54 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 32 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: October 2022
Introduction
The October release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Adult Diseases and Conditions features 3 new entries to replace the old entry on "Headache": Headache (cluster), Headache (migraine), and Headache (tension).
• Likewise, Adult Care Plans offers 3 corresponding new care plans of the same name: Headache (cluster), Headache (migraine), and Headache (tension).
• Treatments includes 7 new Adult Treatments on Airway stents, Biliary drainage catheter (T-tube), Endoleak embolization, Microwave ablation, Thoracic duct embolization, Uterine artery embolization, and Varicocele embolization.
• Diagnostic Tests features 1 new test covering Adrenal vein sampling.
• Sentinel Events was expanded to include 1 new entry titled "Diagnostic overshadowing among groups experiencing health disparities."
• Clinical Guideline Summaries provides 6 new guideline summaries on Acne management, Central line–associated bloodstream infections, Cirrhosis, End-of-life care, Nutritional support, and Pediatric pain prevention and management.
• Drugs includes 4 new FDA-approved drugs this quarter (see details below).
• You'll also find updates to more than 800 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 136 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 3 Adult Diseases and Conditions were added this quarter:
• Headache (cluster)
• Headache (migraine)
• Headache (tension).
• Renamed: None.
• Removed: 1 Adult Diseases and Condition this quarter:
• Headache

Diseases and Conditions (Long-Term Care)

• Updated: 62 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 48 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 61 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: 7 Adult Treatments were added this quarter:
• Airway stent
• Biliary drainage catheter (T-tube)
• Endoleak embolization
• Microwave ablation
• Thoracic duct embolization
• Uterine artery embolization
• Varicocele embolization.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 44 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 126 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: 1 Diagnostic Test entry was added this quarter:
• Adrenal vein sampling.
• Renamed: 4 Diagnostic Tests were renamed this quarter:
• QuantiFERON-TB gold plus test [formerly, QuantiFERON-TB gold test]
• Renal scan [formerly, Radionuclide renal imaging]
• Thyroid scan [formerly, Radionuclide thyroid imaging]
• Triglyceride level test [formerly, Triclycerides level test]
• Removed: None.

Drugs

• Updated: 120 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 4 new Drug monographs were added this quarter:
• ganaxolone: treats seizures associated with cyclin-dependent kinase-like 5 deficiency disorder in children age 2 and older
• mitapivat: used to treat hemolytic anemia in patients with pyruvate kinase (PK) deficiency
• oteseconazole: an antifungal used to reduce incidence of recurrent vulvovaginal candidiasis (RVVC) in patients with a history of RVVC who aren't of childbearing potential
• mavacamten: used for symptomatic NYHA Class II to III obstructive hypertrophic cardiomyopathy to improve functional capacity and symptoms.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 135 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 3 Adult Care Plans were added this quarter:
• Headache (cluster)
• Headache (migraine)
• Headache (tension).
• Renamed: None.
• Removed: 1 Adult Care Plan this quarter:
• Headache

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 62 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 48 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 10 Cultural Perspectives were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Sentinel Events

• Updated: 22 Sentinel Events were reviewed for clinical accuracy and updated as needed.
• New: 1 new Sentinel Event was added this quarter:
• Diagnostic overshadowing among groups experiencing health disparities
• Renamed: None.
• Removed: None.

Core Measures

• Updated: 70 Core Measures were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Improvement Strategies

• Updated: 28 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Quality Improvement Strategy was renamed this quarter:
• First case on-time rate [formerly, Average on-time OR start rate]
• Removed: None.

Quality Indicators

• Updated: 28 Quality Indicators were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Quality Indicators entry was renamed this quarter:
• First case on-time rate [formerly, Average on-time OR start rate]
• Removed: None.

Clinical Guideline Summaries

• Updated: 7 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 6 new Clinical Guideline Summaries were added this quarter:
• Acne vulgaris: Management (2021)
• Central line–associated bloodstream infection: CLABSI prevention in acute care hospitals (2022)
• Cirrhosis: AGA clinical practice guideline on coagulation disorders in cirrhosis (2021)
• End of life care: ESMO clinical practice guidelines (2021)
• Nutritional support: ASPEN/SCCM guidelines for nutrition support therapy in critically ill adult patients (2022)
• Pediatric pain: Clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients (2022).
• Renamed: 7 Clinical Guideline Summaries were renamed this quarter:
• Cancer pain: NCCN clinical practice guidelines for adult cancer pain (2022) [formerly, Cancer pain: NCCN clinical practice guidelines for adult cancer pain (2020)]
• Cataract: Preferred practice pattern for cataract in the adult eye (2021) [formerly, Cataract: Preferred practice pattern for cataract in the adult eye (2016)]
• Heart failure: ACC/AHA guideline for the management of heart failure (2022) [formerly, Heart failure: ACC/AHA guideline for the management of heart failure (2017)]
• Major depressive disorder: VA/DoD clinical practice guideline for the management of major depressive disorder (2022) [formerly, Major depressive disorder: VA/DoD clinical practice guideline for the management of major depressive disorder (2016)]
• Palliative care: NCCN clinical practice guidelines for palliative care (2022) [formerly, Palliative care: NCCN clinical practice guidelines for palliative care (2020)]
• Primary biliary cholangitis: Practice guidance from the American Association for the Study of Liver Diseases (2021) [formerly, Primary biliary cholangitis: Practice guidance from the American Association for the Study of Liver Diseases (2018)]
• Venous thromboembolism (VTE): CHEST guideline and expert panel report on antithrombotic therapy for VTE disease (2021) [formerly, Venous Thromboembolism (VTE): CHEST guideline and expert panel report on antithrombotic therapy for VTE disease (2016)].
• Removed: 6 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Acute pyelonephritis: IDSA and ESCMID clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women (2011)
• Anterior cruciate ligament injuries: AAOS clinical practice guideline on the management of anterior cruciate ligament injuries (2014)
• Celiac disease: ACG clinical guideline on the diagnosis and management of celiac disease (2013)
• Chronic lymphocytic leukemia: NCCN clinical practice guidelines for chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) (2021)
• Chronic myeloid leukemia: NCCN clinical practice guidelines for chronic myeloid leukemia (2020)
• Crohn disease: AGA guideline on the use of thiopurines, methotrexate, and anti–TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn disease (2013).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 48 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 34 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 45 Teaching about Diagnostic Tests entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: July 2022
Introduction
The July release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Treatments includes 4 new Adult Treatments on glucose monitoring, nephrostomy tubes, pleurodesis, and ureteral stents, plus 1 new Pediatric Treatment on glucose monitoring.
• Diagnostic Tests features 5 new tests covering arteriography with embolization, fistulogram, fractional flow reserve, intravascular ultrasound, and venogram.
• Core Measures was expanded to include 1 new Perinatal Care entry on severe obstetric complications.
• Clinical Guideline Summaries provides 5 new guideline summaries on diabetes mellitus, gastroesophageal reflux disease, glomerulonephritis, hip fractures, postoperative delirium, and volvulus.
• Drugs includes 7 new FDA-approved drugs this quarter (see details below).
• You'll also find updates to more than 800 additional entries in various other categories.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 117 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 60 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 50 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Signs and Symptoms

• Updated: 1 Signs and Symtoms entry was reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 60 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: 4 Adult Treatments were added this quarter:
• Continuous glucose monitoring
• Percutaneous nephrostomy tube
• Pleurodesis
• Ureteral stent.
• Renamed: 1 Adult Treatments was renamed this quarter:
• Myomectomy [formerly, Abdominal myomectomy].
• Removed: None.

Treatments (Pediatric)

• Updated: 35 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: 1 Pediatric Treatment was added this quarter:
• Continuous glucose monitoring, pediatric.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 115 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: 5 Diagnostic Tests were added this quarter:
• Arteriography with embolization
• Fistulogram
• Fractional flow reserve
• Intravascular ultrasound
• Venogram.
• Renamed: None.
• Removed: None.

Drugs

• Updated: 135 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 7 new Drug monographs were added this quarter:
• abrocitinib (Cibinqo): treats refractory, moderate to severe atopic dermatitis not adequately controlled with other systemic drug products
• asciminib (Scemblix): helps treat Philadelphia chromosome-positive chronic myeloid leukemia
• cabotegravir (Apretude, Vocabria): provides short-term treatment and preexposure prophylaxis for HIV-1 infection
• daridorexant (Quviviq): helps with insomnia
• inclisiran (Leqvio): helps lower lipid levels in those with hypercholesterolemia or atherosclerotic CV disease
• maribavir (Livtencity): helps treat posttransplant CMV infection
• vosoritide (Voxzogo): increases linear growth in those with achondroplasia with open epiphyses.
• Renamed: None.
• Removed: 4 drug monographs were discontinued and removed this quarter:
• betrixiban (Bevyxxa)
• indacaterol maleate (Onbrez Breezhaler)
• indacaterol maleate–glycopyrrolate (Utibron Neohaler)
• ombitasvir–paritaprevir–ritonavir–dasabuvir (Viekira Pak)

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 118 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 60 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 50 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 24 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Hospital-acquired Conditions

• Updated: 14 Hospital-acquired Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: None.
• New: 1 Core Measure was added this quarter:
• (PC-07) Severe obstetric complications.
• Renamed: None.
• Removed: None.

Quality Indicators

• Updated: 33 Quality Indicator reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Improvement Strategies

• Updated: 33 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 6 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 5 new Clinical Guideline Summaries were added this quarter:
• Anaplastic thyroid cancer: American Thyroid Association (ATA) guidelines for management of patients with anaplastic thyroid cancer (2021)
• Chronic multisymptom illness: VA/DoD clinical practice guideline for the management of chronic multisymptom illness (2021)
• Hypertension in pregnancy: Diagnosis, blood pressure goals, and pharmacotherapy (2022)
• Neurogenic bladder: AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction (2021)
• Substance use disorder: VA/DoD clinical practice guideline for the management of substance use disorder (2021).
• Renamed: 6 Clinical Guideline Summaries were renamed this quarter:
• Diabetes mellitus: ADA standards of medical care in diabetes (2022) [formerly, Diabetes mellitus: ADA standards of medical care in diabetes (2021)]
• Gastroesophageal reflux disease: Guidelines for the diagnosis and management of GERD (2021) [formerly, Gastroesophageal reflux disease: Guidelines for the diagnosis and management of GERD (2013)]
• Glomerulonephritis: KDOQI clinical practice guideline for the management of glomerular disease (2021) [formerly, Glomerulonephritis: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis (2013)]
• Hip fracture: AAOS guideline on the management of hip fractures in the elderly (2021) [formerly, Hip fracture: AAOS guideline on the management of hip fractures in the elderly (2014)]
• Postoperative delirium in older adults: American Geriatrics Society clinical practice guideline for postoperative delirium in older adults (2021) [formerly, Postoperative delirium in older adults: American Geriatrics Society clinical practice guideline for postoperative delirium in older adults (2014)]
• Volvulus: Clinical practice guidelines for colon volvulus and acute colonic pseudo-obstruction (2021) [formerly, Volvulus: Clinical practice guidelines for colon volvulus and acute colonic pseudo-obstruction (2016)].
• Removed: 4 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Alzheimer disease: Practice guideline for the treatment of patients with Alzheimer disease and other dementias (2010)
• Bronchiolitis: AAP guideline on the diagnosis, management, and prevention of bronchiolitis (2014)
• Carbon monoxide poisoning: Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning (2012)
• Thyroid cancer: NCCN clinical practice guideline for thyroid carcinoma (2021).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 51 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 39 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 31 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: April 2022
Introduction
The April release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Adult Diseases and Conditions and their corresponding Adult Care Plans feature 1 new entry on respiratory alkalosis.
• Adult Treatments includes 1 new entry on total parenteral nutrition.
• Clinical Guideline Summaries offers summaries of 5 new guidelines dealing with strategies to prevent Clostridioides difficile infection; screening, treatment, and management of hepatitis C in pregnancy; diagnosing and managing acute hematogenous osteomyelitis in pediatrics; primary care of adult patients after stroke; and managing patients with upper GI and ulcer bleeding in an acute care setting.
• Over 800 Drugs were updated and 5 new FDA-approved Drugs were added this quarter.
• You'll also find updates to more than 900 additional entries in various other categories.
• And, finally, the Health Library 1 new edition of a previously published text. See below for further details.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 117 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 1 new Adult Diseases and Conditions was added this quarter:
• Respiratory alkalosis.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 62 Long-Term Care Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 45 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Pediatric Diseases and Conditions was renamed this quarter:
• Measles (rubeola), pediatric [formerly, Rubeola, pediatric].
• Removed: None.

Treatments (Adult)

• Updated: 58 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: 1 Adult Treatment was added this quarter:
• Total parenteral nutrition.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 31 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 127 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 2 Diagnostic Tests were renamed this quarter:
• Capsule endoscopy [formerly, Given diagnostic imaging]
• Hemoglobin level (serum) [formerly, Hemoglobin level test].
• Renamed: None.

Drugs

• Updated: 810 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Boxed Warnings), and other pertinent nursing information.
• New: 5 new Drug monographs were added this quarter:
• atogepant (Qulipta)
• avacopan (Tavneos)
• difelikefalin (Korsuva)
• maralixibat (Livmarli)
• mobocertinib (Exkivity).
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 128 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 1 new Adult Care Plan was added this quarter:
• Respiratory alkalosis.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 62 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 45 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Pediatric Care Plan was renamed this quarter:
• Measles (rubeola), pediatric [formerly, Rubeola, pediatric].
• Removed: None.

Problem-based Care Plans

• Updated: 22 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

National Patient Safety Goals

• Updated: 12 National Patient Safety Goals were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: 69 Core Measures were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 6 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 5 new Clinical Guideline Summaries were added this quarter:
• Clostridioides difficile: Strategies to prevent Clostridioides difficile infection in acute care facilities (2021)
• Hepatitis C in pregnancy: Society for Maternal-Fetal Medicine guidelines for hepatitis C in pregnancy (2021)
• Pediatric osteomyelitis: Pediatric Infectious Diseases Society/Infectious Diseases Society of America guidelines for the diagnosis and management of acute hematogenous osteomyelitis in pediatrics (2021)
• Stroke: American Heart Association/American Stroke Association guidelines on the primary care of adult patients after stroke (2021)
• Upper GI and ulcer bleeding: American College of Gastroenterology clinical guideline on upper GI and ulcer bleeding (2021).
• Renamed: 6 Clinical Guideline Summaries were renamed this quarter:
• Acquired immunodeficiency syndrome: CDC/NIH/HIV Medicine Association of the IDSA guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents (2021) [formerly, Acquired immunodeficiency syndrome: CDC/NIH/HIV Medicine Association of the IDSA guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents (2018)]
• Acquired immunodeficiency syndrome: DHHS guidelines for the use of antiretroviral agents in adults and adolescents with HIV (2021) [formerly, Acquired immunodeficiency syndrome: DHHS guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents (2018)]
• Ankylosing spondylitis: American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network treatment recommendations for ankylosing spondylitis (2019) [formerly, Ankylosing spondylitis: American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network treatment recommendations (2016)]
• Chronic obstructive pulmonary disease: VA/DoD clinical practice guideline for the management of COPD (2021) [formerly, Chronic obstructive pulmonary disease: VA/DoD clinical practice guideline for the management of COPD (2014)]
• Clostridioides difficile infection: IDSA/SHEA clinical practice guidelines for Clostridioides difficile infection in adults and children (2021) [formerly, Clostridium difficile infection: IDSA/SHEA clinical practice guidelines for Clostridium difficile infection in adults and children (2018)]
• Sepsis: Surviving Sepsis Campaign international guideline update for the management of sepsis and septic shock (2021) [formerly, Sepsis: The Surviving Sepsis Campaign guideline update for the management of sepsis and septic shock (2018)].
• Removed: 10 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Central nervous system cancer: NCCN clinical practice guidelines for central nervous system cancers (2021)
• Complex regional pain syndrome: Practical diagnostic and treatment guidelines, 4th ed. (2013)
• Dyspepsia: ACG and CAG guideline on the management of dyspepsia (2017)
• Gastroesophageal reflux disease: AGA medical position statement on management of GERD (2008)
• Obesity: ASCO clinical practice guideline on the appropriate chemotherapy dosing for obese adult patients with cancer (2012)
• Obstructive sleep apnea: Clinical guideline for the evaluation, management, and long-term care of obstructive sleep apnea in adults (2009)
• Obstructive sleep apnea: Practice parameters for the medical therapy of obstructive sleep apnea (2006)
• Occult primary cancer: NCCN clinical practice guidelines for occult primary (cancer of unknown primary [CUP]) (2020)
• Osteoporosis: Endocrine Society clinical practice guideline on osteoporosis in men (2012)
• Penile cancer: NCCN clinical practice guideline for penile cancer (2020).

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching Challenges

• Updated: 9 Teaching Challenges entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching Concepts

• Updated: 21 Teaching Concepts entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diseases and Conditions

• Updated: 27 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 27 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 43 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

HEALTH LIBRARY

• Updated: 1 new edition was added, replacing an older edition:
• Nutrition in Clinical Practice: A Comprehensive Evidence-Based Manual for the Practitioner, 4th ed. (Replaces Nutrition in Clinical Practice: A Comprehensive Evidence-Based Manual for the Practitioner, 3rd ed.)
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: January 2022
Introduction
The January release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Adult Diseases and Conditions and their corresponding Adult Care Plans have been expanded to include 3 new entries covering Metabolic acidosis, Metabolic alkalosis, and Neutropenic fever.
• Pediatric Treatments includes 1 new entry on Total parenteral nutrition.
• Clinical Guideline Summaries features summaries of 7 new guidelines dealing with COVID-19, Obesity, Pediatric tracheostomy management, Medication safety, Smart infusion pumps, Transgender health, and Ethical issues with vaccination in obstetrics and gynecology.
• And finally, 6 new FDA-approved Drugs were added this quarter.
• You'll also find updates to more than 1,090 entries in various other categories, as specified below.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 128 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 3 new Adult Diseases and Conditions were added this quarter:
• Metabolic acidosis
• Metabolic alkalosis
• Neutropenic fever.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 64 Long-Term Care Diseases were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 45 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 52 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 35 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: 1 new Pediatric Treatment was added this quarter:
• Total parenteral nutrition, pediatric.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 120 Diagnostic Tests were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Diagnostic Test was renamed this quarter:
• Acid-fast bacilli (AFB) test [formerly, Acid-fast stain].
• Removed: 1 Diagnostic Test was removed this quarter:
• Arginine level test.

Drugs

• Updated: 190 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Black Box Warnings), and other pertinent nursing information.
• New: 6 new Drug monographs were added this quarter:
• belumosudil (Rezurock)
• finerenone (Kerendia)
• ibrexafungerp (Brexafemme)
• odevixibat (Bylvay)
• pegcetacoplan (Empaveli)
• relugolix–estradiol–norethindrone acetate (Myfembree)
• Renamed: None.
• Removed: 2 Drugs were discontinued by the FDA and removed this quarter:
• methyldopa–hydroCHLOROthiazide
• nadolol–bendroflumethiazide

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 126 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 3 new Adult Care Plans were added this quarter:
• Metabolic acidosis
• Metabolic alkalosis
• Neutropenic fever.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 64 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 45 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 15 Cultural Perspectives entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 9 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 7 new Clinical Guideline Summaries were added this quarter:
• COVID 19 management: Management of hospitalized adults with coronavirus disease 2019 (COVID-19) (2021)
• Medication safety: ISMP guidelines for optimizing safe implementation and use of smart infusion pumps (2020)
• Medication safety: ISMP targeted medication safety best practices for hospitals (2020)
• Obesity: Obesity in pregnancy (2021)
• Pediatric tracheostomy management: Management of pediatric patients with tracheostomy in the acute care setting (2021)
• Transgender health: ACOG committee opinion on health care for transgender and gender diverse individuals (2021)
• Vaccines: ACOG committee opinion on ethical issues with vaccination in obstetrics and gynecology (2021).
• Renamed: 9 Clinical Guideline Summaries were renamed this quarter:
• Cirrhosis: AASLD update on the management of patients with ascites due to cirrhosis (2021) [formerly, Cirrhosis: AASLD update on the management of adult patients with ascites due to cirrhosis (2012)]
• Clostridioides difficile infection: Guidelines for the diagnosis, treatment, and prevention of Clostridioides difficile infections (2021) [formerly, Clostridium difficile infection: Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections (2013)]
• Concussion: VA/DoD clinical practice guideline for the management of concussion–mild traumatic brain injury (2021) [formerly, Concussion: VA/DoD clinical practice guideline for the management of concussion–mild traumatic brain injury (2016)]
• Neuroendocrine and adrenal tumors: NCCN clinical practice guidelines for neuroendocrine and adrenal tumors (2021) [formerly, Neuroendocrine and adrenal tumors: NCCN clinical practice guidelines on neuroendocrine and adrenal tumors (2019)]
• Rheumatoid arthritis: ACR guideline for the treatment of rheumatoid arthritis (2021) [formerly, Rheumatoid arthritis: ACR guideline for the treatment of rheumatoid arthritis (2015)]
• Sexually transmitted infections: CDC STI treatment guidelines (2021) [formerly, Sexually transmitted diseases: STD treatment guidelines (2015)]
• Small bowel adenocarcinoma: NCCN clinical practice guidelines for small bowel adenocarcinoma (2021) [formerly, Small bowel adenocarcinoma: NCCN clinical practice guidelines on small bowel adenocarcinoma (2019)]
• Thyroid cancer: NCCN clinical practice guideline for thyroid carcinoma (2021) [formerly, Thyroid cancer: NCCN clinical practice guideline for thyroid carcinoma (2020)]
• Vulvar cancer: NCCN clinical practice guideline for vulvar cancer (squamous cell carcinoma) (2021) [formerly, Vulvar cancer: NCCN clinical practice guideline for vulvar cancer (squamous cell carcinoma) (2020)].
• Removed: 7 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Acute lower gastrointestinal bleeding: ASGE Standards of Practice Committee on the role of endoscopy in the patient with lower GI bleeding (2014)
• Alpha-1 antitrypsin deficiency: Diagnosis and management of alpha-1 antitrypsin deficiency in the adult (2016)
• Amyotrophic lateral sclerosis: AAN practice parameter update on care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) (2009)
• Cardiomyopathy: AHA/ACCF clinical update on hypertrophic cardiomyopathy (2018)
• Deep vein thrombosis: AAOS guideline on preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty (2011)
• Lupus nephritis: ACR guidelines for screening, treatment, and management of lupus nephritis (2012)
• Small bowel bleeding: American College of Gastroenterology guidelines for the diagnosis and management of small bowel bleeding (2015).

Nursing Management

• Updated: 27 Nursing Management entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Education

• Updated: 27 Clinical Education entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 54 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 32 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Teaching about Treatments entry was renamed this quarter:
• Mechanical ventilation (positive pressure) [formerly, Mechanical ventilation].
• Removed: None.

Teaching about Diagnostic Tests

• Updated: 38 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: October 2021
Introduction
The October release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• There are 4 new Adult Diseases and Conditions with corresponding Adult Care Plans this quarter, including Gestational diabetes, Hypercalcemia of malignancy, Hyperosmolar hyperglycemic state, and Hyperviscosity syndrome.
• Clinical Guideline Summaries has been expanded to include 6 new guidelines and updates to 8 existing guideline entries this quarter. Included are summaries of the latest clinical practice guidelines for surviving sepsis with COVID 19, cancer treatments, irritable bowel syndrome, and skin toxicity. See below for a complete list of new entries.
• Also included are 10 new FDA-approved Drugs as well as updates to 112 existing drug monographs.
• Additionally, you'll find updates to over 865 entries in various other categories, as specified below.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 134 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: 4 new Adult Diseases and Conditions were added this quarter:
• Gestational diabetes
• Hypercalcemia of malignancy
• Hyperosmolar hyperglycemic state
• Hyperviscosity syndrome
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 62 Long-Term Care Diseases were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 46 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 62 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 45 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Pediatric Treatment was renamed for clinical or editorial accuracy:
• Mechanical ventilation (positive pressure), pediatric [formerly, Mechanical ventilation, pediatric]
• Removed: None.

Drugs

• Updated: 112 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Black Box Warnings), and other pertinent nursing information.
• New: 10 new Drug monographs were added this quarter:
• cabotegravir–rilpivirine(Cabenuva)
• dasiglucagon (Zegalogue)
• drospirenone–estetrol (Nextstellis)
• melphalan flufenamide (Pepaxto)
• ponesimod (Ponvory)
• serdexmethylphenidate–dexmethylphenidate (Azstarys)
• tepotinib (Tepmetko)
• tivozanib (Fotivda)
• trilaciclib (Cosela)
• viloxazine (Qelbree)
• Renamed: None.
• Removed: 2 Drugs were discontinued by the FDA and removed this quarter:
• peginterferon alfa-2b
• stavudine

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 132 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: 4 new Adult Care Plans were added this quarter:
• Gestational diabetes
• Hypercalcemia of malignancy
• Hyperosmolar nonketotic coma
• Hyperviscosity syndrome
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 62 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 46 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 23 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Hospital-acquired Conditions

• Updated: 3 Hospital-acquired Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 15 Cultural Perspectives entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Sentinel Events

• Updated: 22 Sentinel Events entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 8 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 6 new Clinical Guideline Summaries were added this quarter:
• Beers Criteria: American Geriatrics Society AGS Beers Criteria for potentially inappropriate medication use in older adults (2019)
• COVID-19: Surviving Sepsis Campaign guidelines on the management of adults with COVID-19 in the ICU (2021)
• Hot flashes: ONS guidelines for cancer treatment-related hot flashes in women with breast cancer and men with prostate cancer (2020)
• Irritable bowel syndrome: ACG Clinical Guideline on the management of irritable bowel syndrome (2021)
• Lymphedema: Oncology Nursing Society (ONS) guidelines for cancer treatment and related lymphedema (2020)
• Skin toxicity: ONS guidelines for cancer treatment-related skin toxicity (2020)
• Renamed: 8 Clinical Guideline Summaries were renamed this quarter:
• Anal carcinoma: NCCN clinical practice guidelines for anal carcinoma (2021) (formerly, Anal carcinoma: NCCN clinical practice guidelines for anal carcinoma [2019])
• Chronic lymphocytic leukemia: NCCN clinical practice guidelines for chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) (2021) (formerly, Chronic lymphocytic leukemia: NCCN clinical practice guidelines for chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia [SLL] [2019])
• Central nervous system cancer: NCCN clinical practice guidelines for central nervous system cancers (2021) (formerly, Central nervous system cancer: NCCN clinical practice guidelines for central nervous system cancers [2019])
• Diabetes mellitus: ADA standards of medical care in diabetes (2021) (formerly, Diabetes mellitus: ADA standards of medical care in diabetes [2019])
• Gestational hypertension and preeclampsia: ACOG practice bulletin on gestational hypertension and preeclampsia (2020) (formerly, Gestational hypertension and preeclampsia: ACOG practice bulletin on gestational hypertension and preeclampsia [2019])
• Head and neck cancers: NCCN clinical practice guideline for head and neck cancers (2021) (formerly, Head and neck cancers: NCCN clinical practice guideline for head and neck cancers [2019])
• Hereditary angioedema: US HAEA Medical Advisory Board guidelines for the management of hereditary angioedema (2020) (formerly, Hereditary Angioedema: US Hereditary Angioedema Association Medical Advisory Board recommendations for the management of HAE due to C1 inhibitor deficiency [2013])
• Small cell lung cancer: NCCN guidelines for small cell lung cancer (2021) (formerly, Small cell lung cancer: NCCN guidelines for small cell lung cancer [2020])
• Removed: 6 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Endometriosis: Evaluation and treatment of endometriosis (2013)
• Hyponatremia: Compilation of guidelines on the diagnosis and treatment of hyponatremia (2017)
• Obesity: ACC/AHA/TOS guideline for the management of overweight and obesity in adults, a report (2013)
• Polycystic ovary syndrome: Endocrine Society clinical practice guideline on the diagnosis and treatment of polycystic ovary syndrome (2013)
• Pneumothorax: Practice management guidelines for management of hemothorax and occult pneumothorax (2011)
• Pneumothorax: BTS pleural disease guideline on the management of spontaneous pneumothorax (2010)

Core Measures

• Updated: 69 Core Measures were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Indicators

• Updated: 28 Quality Indicators were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Improvement Strategies

• Updated: 28 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 48 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 35 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Return to Top

Release: July 2021
Introduction
The July release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Clinical Guideline Summaries has been expanded to include 5 new guidelines and updates to 7 existing guideline entries this quarter. Included are summaries of the latest clinical practice guidelines for asthma, chronic kidney disease, CVC-related infections, depression, and Lyme disease. See below for a complete list of new entries.
• Also included are 8 new FDA-approved Drugs as well as updates to 110 existing drug monographs.
• Additionally, you'll find updates to over 750 entries in various other categories, as specified below.
• And, finally, the Health Library has been updated to include 7 new titles and 9 new editions of existing titles. See below for further details.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 118 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 60 Long-Term Care Diseases were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Long-Term Care Disease was renamed for clinical or editorial accuracy:
• Vancomycin-resistant enterococci infection, long-term care [formerly, Vancomycin-resistant enterococci, long-term care]
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 50 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diagnostic Tests

• Updated: 1 Diagnostic Test was reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 60 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 35 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 Pediatric Treatment was renamed for clinical or editorial accuracy:
• Chemotherapy (intravenous), pediatric [formerly, Chemotherapy, pediatric]
• Removed: None.

Drugs

• Updated: 110 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Black Box Warnings), and other pertinent nursing information.
• New: 8 new Drug monographs were added this quarter:
• berotralstat (Orladeyo)
• capmatinib (Tabrecta)
• lumasiran (Oxlumo)
• relugolix (Orgovyx)
• tirbanibulin (Klisyri)
• vericiguat (Verquvo)
• vibegron (Gemtesa)
• voclosporin (Lupkynis)
• Renamed: None.
• Removed: 1 Drug was discontinued by the FDA and removed this quarter:
• indinavir sulfate

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 118 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 60 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 50 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 24 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Hospital-acquired Conditions

• Updated: 14 Hospital-acquired Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Cultural Perspectives

• Updated: 17 Cultural Perspectives entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 7 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 5 new Clinical Guideline Summaries were added this quarter:
• Asthma: VA/DoD clinical practice guideline for the primary care management of asthma (2019)
• Chronic kidney disease: VA/DoD clinical practice guideline for the management of chronic kidney disease (2019)
• CVC-related infections: Updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) (2020)
• Depression: American Psychological Association clinical practice guideline for the treatment of depression across three age cohorts (2019)
• Lyme disease: IDSA, AAN, and ACR clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease (2020)
• Renamed: 5 Clinical Guideline Summaries were renamed this quarter:
• Macular degeneration: American Academy of Ophthalmology preferred practice pattern on age-related macular degeneration (2019) (formerly, Macular degeneration: American Academy of Ophthalmology preferred practice pattern on age-related macular degeneration [(2015])
• Multiple sclerosis: AAN summary of the evidence-based guideline on complementary and alternative medicine in multiple sclerosis (2020) (formerly, Multiple sclerosis: AAN summary of the evidence-based guideline on complementary and alternative medicine in multiple sclerosis [2014])
• Pelvic organ prolapse: American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society practice parameter on pelvic organ prolapse (2019) (formerly, Pelvic organ prolapse: American College of Obstetricians and Gynecologists [ACOG] and the American Urogynecologic Society practice parameter on pelvic organ prolapse [2017])
• Prostate cancer: NCCN guidelines on prostate cancer (2020) (formerly, Prostate cancer: NCCN guidelines on prostate cancer [2018])
• Renal calculi: American Urological Association guideline on the medical management of kidney stones (2019) (formerly, Renal calculi: American Urological Association guideline on the medical management of kidney stones [2014])
• Removed: 7 outdated Clinical Guideline Summaries were removed or replaced with newer guidelines this quarter:
• Asthma: ERS and ATS guidelines on the definition, evaluation, and treatment of severe asthma (2013)
• Kidney disease chronic: ACP clinical practice guideline on screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease (2013)
• Kidney disease chronic: KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease (2012)
• Major depressive disorder: APA practice guideline for the treatment of patients with major depressive disorder (2010)
• Pulmonary hypertension: ACCF/AHA expert consensus document on pulmonary hypertension (2009)
• Renal calculi: ACP clinical practice guideline on the dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults (2014)
• Urinary incontinence: ACP clinical practice guideline on the nonsurgical management of urinary incontinence in women (2014)

Quality Indicators

• Updated: 33 Quality Indicators were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Quality Improvement Strategies

• Updated: 34 Quality Improvement Strategies were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

PATIENT TEACHING NAVIGATOR CONTENT SETS

Teaching about Diseases and Conditions

• Updated: 52 Teaching about Diseases and Conditions entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Teaching about Treatments

• Updated: 39 Teaching about Treatments entries were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

HEALTH LIBRARY

• Updated: 9 new editions were added, replacing older editions:
• Perpetua: Cardiac Nursing, 7th ed. (Replaces Cardiac Nursing, 6th ed.)
• Simpson: Perinatal Nursing, 5th ed. (Replaces Perinatal Nursing, 4th ed.)
• Briggs: Telephone Triage Protocols for Nurses, 6th ed. (Replaces Telephone Triage Protocols for Nurses, 5th ed.)
• Ayello: Wound Care Essentials: Practice Principles, 5th ed. (Replaces Wound Care Essentials: Practice Principles, 4th ed.)
• Ramasethu: MacDonald's Atlas of Procedures in Neonatology, 6th ed. (Replaces Atlas of Procedures in Neonatology, 5th ed.)
• Bickley: Bates' Guide to Physical Examination and History Taking, 13th ed. (Replaces Bates' Guide to Physical Examination and History Taking, 12th ed.)
• Swiontkowski: Manual of Orthopaedics, 8th ed. (Replaces Manual of Orthopaedics, 7th ed.)
• Klingensmith: The Washington Manual of Surgery, 8th ed. (Replaces The Washington Manual of Surgery, 7th ed.)
• Rao: Wallach's Interpretation of Diagnostic Tests, 11th ed. (Replaces Wallach's Interpretation of Diagnostic Tests, 10th ed.)
• New: 7 new titles were added this release:
• Bobonich: Dermatology for Advanced Practice Clinicians: A Comprehensive Guide to Diagnosis and Treatment, 2nd ed.
• Menihan: Electronic Fetal Monitoring: Concepts and Applications, 3rd ed.
• Rundio: Nurse Management & Executive Practice, 1st ed.
• Starkweather: Pain Management for Advanced Practice: Multimodal Approaches, 1st ed.
• Diepenbrock: Quick Reference to Critical Care, 6th ed.
• Zane: Pocket Notebook: Pocket Emergency Medicine, 4th ed.
• Peitzman: The Trauma Manual: Trauma and Acute Care Surgery, 5th ed.
• Removed: 7 titles were removed this release:
• Rowland: Clinical Pharmacokinetics: Concepts and Applications, 4th ed.
• LWW: Lippincott's Q&A Certification Review: Emergency Nursing, 2nd ed. (Current edition is already live)
• LWW: Lippincott's Review for Medical-Surgical Nursing Certification, 5th ed. (Current edition is already live)
• Jensen: Pocket Guide for Nursing Health Assessment: A Best Practice Approach, 2nd ed.
• Scott-Ricci: Essentials of Maternity, Newborn, and Women's Health Nursing, 4th ed.
• Gibbs: Danforth's Obstetrics and Gynecology, 10th ed.
• Egan: Essential Emergency Trauma, 1st ed.

Return to Top

Release: April 2021
Introduction
The April release of Lippincott Advisor reflects the following enhancements:

NEW CONTENT

• Clinical Guideline Summaries has been expanded to include 8 new guidelines and updates to 20 existing guideline entries this quarter. Included are summaries of the latest clinical practice guidelines for achalasia, chronic pancreatitis, gender dysphoria, headache, and nonsurgical osteoarthritis management, to name a few. See below for a complete list of new entries.
• Also included are 4 new FDA-approved Drugs as well as updates to over 850 existing drug monographs.

LIPPINCOTT ADVISOR CONTENT SETS

Diseases and Conditions (Adult)

• Updated: 119 Adult Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Long-Term Care)

• Updated: 63 Long-Term Care Diseases were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Diseases and Conditions (Pediatric)

• Updated: 45 Pediatric Diseases and Conditions were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Adult)

• Updated: 58 Adult Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Treatments (Pediatric)

• Updated: 31 Pediatric Treatments were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Drugs

• Updated: Over 850 Drug monographs were updated this release. Additionally, weekly Latest Updates (found at the top of related monographs) were added, as warranted, to cover new FDA-approved indications and dosages, warnings and alerts (including Black Box Warnings), and other pertinent nursing information.
• New: 4 new Drug monographs were added this quarter:
• clascoterone (Winlevi)
• oliceridine (Olinvyk)
• pralsetinib (Gavreto)
• risdiplam (Evrysdi)
• Renamed: None.
• Removed: 1 Drug monograph was discontinued and removed this quarter:
• doripenem

Nursing Care Plans for Medical Diagnoses (Adult)

• Updated: 118 Adult Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Long-Term Care)

• Updated: 62 Long-Term Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Nursing Care Plans for Medical Diagnoses (Pediatric)

• Updated: 45 Pediatric Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Problem-based Care Plans

• Updated: 22 Problem-based Care Plans were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: None.
• Removed: None.

Core Measures

• Updated: 68 Core Measures were reviewed for clinical accuracy and updated as needed.
• New: 1 new Core Measure was added this quarter:
• (OPI-1) Safe use of opioids – concurrent prescribing
• Renamed: None.
• Removed: None.

Clinical Guideline Summaries

• Updated: 20 Clinical Guideline Summaries were reviewed for clinical accuracy and updated as needed.
• New: 8 new Clinical Guideline Summaries were added this quarter:
• Achalasia: American College of Gastroenterology clinical guideline on the diagnosis and management of achalasia (2020)
• Chronic pancreatitis: American College of Gastroenterology clinical guideline on chronic pancreatitis (2020)
• Colonic diverticulitis: American Society of Colon and Rectal Surgeons clinical practice guidelines for the treatment of left-sided colonic diverticulitis (2020)
• Epistaxis: American Academy of Otolaryngology clinical practice guideline on epistaxis (2020)
• Gender dysphoria: Endocrine treatment of gender-dysphoric/gender-incongruent persons (2018)
• Headache: VA/DoD clinical practice guideline for the primary care management of headache (2020)
• M鮩貥 disease: Clinical practice guideline for M鮩貥 disease (2020)
• Osteoarthritis: VA/DoD clinical practice guideline for the nonsurgical management of hip and knee osteoarthritis (2020)
• Renamed: 20 Clinical Guideline Summaries were renamed for clinical or editorial accuracy:
• Cervical cancer: NCCN clinical practice guidelines for cervical cancer (2020) [formerly, Cervical cancer: NCCN clinical practice guidelines for cervical cancer (2018)]
• Chronic myeloid leukemia: NCCN clinical practice guidelines for chronic myeloid leukemia (2020) [formerly, Chronic myeloid leukemia: NCCN clinical practice guidelines for chronic myeloid leukemia (2019)]
• Colon cancer: NCCN clinical practice guidelines for colon cancer (2020) [formerly, Colon cancer: NCCN clinical practice guidelines for colon cancer (2019)]
• Esophageal cancer: NCCN clinical practice guidelines for esophageal and esophagogastric junction cancers (2020) [formerly, Esophageal cancer: NCCN clinical practice guidelines for esophageal and esophagogastric junction cancers (2019)]
• Hepatitis C: AASLD-IDSA updated guideline recommendations for testing, managing, and treating hepatitis C virus infection (2019) [formerly, Hepatitis C: AASLD-IDSA updated guideline recommendations for testing, managing, and treating hepatitis C virus infection (2018)]
• Hodgkin lymphoma: NCCN clinical practice guideline for Hodgkin lymphoma (2020) [formerly, Hodgkin lymphoma: NCCN clinical practice guideline for Hodgkin lymphoma (2018)]
• Kidney cancer: NCCN clinical practice guideline for kidney cancer (2020) [formerly, Kidney cancer: NCCN clinical practice guideline for kidney cancer (2019)]
• Malignant pleural mesothelioma: NCCN clinical practice guideline for malignant mesothelioma (2020) [formerly, Malignant pleural mesothelioma: NCCN clinical practice guideline for malignant mesothelioma (2019)]
• Multiple myeloma: NCCN guidelines on multiple myeloma (2020) [formerly, Multiple myeloma: NCCN guidelines on multiple myeloma version (2020)]
• Non-small cell lung cancer: NCCN guidelines on non-small cell lung cancer (2020) [formerly, Non-small cell lung cancer: NCCN guidelines on non-small cell lung cancer (2019)]
• Obesity: VA/DoD clinical practice guideline for the management of adult overweight and obesity (2020) [formerly, Obesity: VA/DoD clinical practice guideline for screening and management of overweight and obesity (2014)]
• Occult primary cancer: NCCN clinical practice guidelines for occult primary cancer (cancer of unknown primary [CUP]) (2020) [formerly, Occult primary cancer: NCCN clinical practice guidelines for occult primary (cancer of unknown primary [CUP]) (2019)]
• Osteoporosis: AACE/ACE clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis (2020) [formerly, Osteoporosis: AACE/ACE clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis (2016)]
• Ovarian cancer: NCCN guidelines on ovarian cancer including fallopian tube cancer and primary peritoneal cancer (2020) [formerly, Ovarian cancer: NCCN guidelines on ovarian cancer including fallopian tube cancer and primary peritoneal cancer (2018)]
• Palliative care: NCCN clinical practice guidelines for palliative care (2020) [formerly, Palliative care: NCCN clinical practice guidelines for palliative care (2019)]
• Penile cancer: NCCN clinical practice guideline for penile cancer (2020) [formerly, Penile cancer: NCCN clinical practice guideline for penile cancer (2018)]
• Rectal cancer: NCCN clinical practice guidelines for rectal cancer (2020) [formerly, Rectal cancer: NCCN clinical practice guidelines for rectal cancer (2019)]
• Soft tissue sarcoma: NCCN clinical practice guidelines for soft tissue sarcoma (2020) [formerly, Soft tissue sarcoma: NCCN clinical practice guidelines for soft tissue sarcoma (2019)]
• Survivorship: NCCN guidelines on survivorship (2020) [formerly, Survivorship: NCCN guidelines on survivorship (2018)]
• Uterine neoplasms: NCCN clinical practice guideline for uterine neoplasms (2020) [formerly, Uterine neoplasms: NCCN clinical practice guideline for uterine neoplasms (2019)]
• Removed: 6 Clinical Guideline Summaries were removed this quarter:
• Breast reconstruction: American Society of Plastic Surgeons guideline for breast reconstruction with expanders and implants (2013)
• Diabetic ketoacidosis: ADA standards of medical care in diabetes (2017)
• Diverticular disease: Practice parameters for the treatment of sigmoid diverticulitis (2014)
• Hypokalemia: National Council on Potassium in Clinical Practice guidelines for potassium replacement, a contempoary review (2000)
• Sarcoidosis: FSR sarcoidosis treatment guidelines (2010)
• Sarcoidosis: Pulmonary fibrosis in sarcoidosis, clinical features and outcomes (2013)

National Patient Safety Goals

• Updated: 12 National Patient Safety Goals were reviewed for clinical accuracy and updated as needed.
• New: None.
• Renamed: 1 National Patient Safety Goal was renamed for clinical accuracy:
• (NPSG.07.01.01) Comply with either the current Centers for Disease Control and Prevention (CDC) hand hygiene guidelines and/or the current World Health Organization (WHO) hand hygiene guidelines [formerly, (NPSG.7.01.01) Comply with either the current Center for Disease Control and Prevention (CDC) or the current World Health Organization (WHO) hand hygiene guidelines]
• Removed: 5 National Patient Safety Goals were removed this quarter:
• (NPSG.01.03.01) Eliminate transfusion errors related to patient misidentification
• (NPSG.07.03.01) Implement evidence-based practices to prevent health care-associated infections due to multi-drug resistant organisms
• (NPSG.07.04.01) Implement evidence-based practices to prevent central line-associated bloodstream infections
• (NPSG.07.05.01) Implement evidence-based practices for preventing surgical site infections
• (NPSG.07.06.01) Implement evidence-based practices to prevent indwelling catheter-associated urinary tract infections (CAUTI)